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background:  Current data supports a link between arterial remodeling and cardiovascular risk. This analysis investigates whether 
ascending aortic index (AAI) improves the risk assessment by the Framingham 10-year general cardiovascular risk score (FGCRS) for 
cardiovascular events and mortality. We also analyze whether AAI is associated with these outcomes independent of factors included in 
most risk score models.
Methods:  The Multi-Ethnic Study of Atherosclerosis is a longitudinal study of subclinical markers of cardiovascular disease (CVD) in an 
ethnically diverse cohort. We identified 3,542 participants with baseline magnetic resonance images of aortic size and clinical follow-up. 
The composite of CVD and mortality was defined as myocardial infarction or revascularization, congestive heart failure, peripheral vascular 
disease, cerebrovascular disease, and all-cause mortality. Logistic regression models adjusting for race and FGCRS assessed whether AAI 
improved the area under the curve (AUC) for the composite end-point. Next, logistic regression models assessed the association between 
AAI and the composite end-point as well as a separate model for all-cause mortality. The models were adjusted for age, race, gender, 
tobacco use, body mass index, blood pressure, antihypertensives, diabetes mellitus, triglycerides, lipid-lowering medications, high density 
lipoprotein and total cholesterol.
Results:  In this cohort, 518 (14.6%) had a composite end-point. AAI improved the AUC for the composite of CVD and mortality (0.72 vs. 
0.69; p = 0.057). AAI was associated with the composite of CVD and mortality in the univariate odds ratio (OR): 1.09 (95% CI: 1.05-1.13) 
and the fully adjusted model OR: 1.07 (95% CI: 1.02-1.14). AAI was associated with all-cause mortality in the univariate OR: 1.14 (95% CI: 
1.09-1.2) and also in the fully adjusted model OR: 1.10 (95% CI: 1.03-1.19). The association of AAI with the composite outcome was driven 
by its association with increased all-cause mortality.
conclusion:  AAI is independently associated with the composite of CVD and mortality, which was predominantly due to its association 
with all-cause mortality. AAI improved the discrimination of the FGCRS.
